Tiny skin study peers inside psoriasis treatment
NCT ID NCT07244744
First seen Nov 24, 2025 · Last updated May 23, 2026 · Updated 28 times
Summary
This study looks at how the drug tildrakizumab works in the skin of 3 adults with moderate to severe plaque psoriasis. Researchers will take small skin samples before and after treatment to see how immune cells change. The goal is to understand why the drug works well for some people and for how long.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CCIM, Institut für Entzündungsmedizin UKSH Lübeck
Lübeck, <Keine Auswahl>, 23562, Germany
Conditions
Explore the condition pages connected to this study.